By Rhodes Hambrick
Peer Reviewed
The atherosclerotic cardiovascular disease (ASCVD) risk associated with hyperlipidemia (HLD), readily apparent from the Framingham Heart Study1 of the mid-20th century, has been the target of innumerable attempted pharmacologic interventions …
By Jonathan Glatt
By Elissa Driggin
By James Barger
By Tyler Litton, MD
By Matthew B. McNeill, MD
By David Valentine, MD
By David Pineles, MD